These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2019711)

  • 41. Pharmacokinetics of fenoterol in pregnant and nonpregnant women.
    Hildebrandt R; Weitzel H; Warnke K; Gundert-Remy U
    Eur J Clin Pharmacol; 1993; 45(3):275-7. PubMed ID: 8276054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Controlled release infusion kinetics of tobramycin.
    Lane JR; Murray WE; Willenborg NL; Wilcox CL; Connor JD; Adler DS
    Ther Drug Monit; 1989; 11(3):264-8. PubMed ID: 2728084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Umbilical versus peripheral tobramycin administration.
    Maddox RR; Purohit DM; Williams MG; Lampasona V; Kunka RL
    Ther Drug Monit; 1986; 8(4):446-50. PubMed ID: 3824431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of a bacterial lipopolysaccharide on the pharmacokinetics of tobramycin in rats.
    Nadai M; Hasegawa T; Kato K; Wang L; Nabeshima T; Kato N
    J Pharm Pharmacol; 1993 Nov; 45(11):971-4. PubMed ID: 7908039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of piperacillin during pregnancy.
    Heikkilä A; Erkkola R
    J Antimicrob Chemother; 1991 Sep; 28(3):419-23. PubMed ID: 1960122
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioavailability of tobramycin after oral delivery in FVB mice using CRL-1605 copolymer, an inhibitor of P-glycoprotein.
    Banerjee SK; Jagannath C; Hunter RL; Dasgupta A
    Life Sci; 2000 Sep; 67(16):2011-6. PubMed ID: 11072877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of oral activated charcoal on tobramycin clearance.
    Davis RL; Koup JR; Roon RA; Opheim KE; Smith AN
    Antimicrob Agents Chemother; 1988 Feb; 32(2):274-5. PubMed ID: 3364947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of endotoxin on tobramycin pharmacokinetics in young and aged rats.
    Wasfi IA
    Pharmacology; 1993 Oct; 47(4):261-7. PubMed ID: 8234415
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A prospective study of antipyrine pharmacokinetics in pregnancy].
    Asymbekova GU
    Akush Ginekol (Mosk); 1995; (2):19-22. PubMed ID: 7785732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disposition of ornidazole and its metabolites during pregnancy.
    Bourget P; Dechelette N; Fernandez H; Desmaris VQ
    J Antimicrob Chemother; 1995 May; 35(5):691-6. PubMed ID: 7592184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heparin interferes with tobramycin serum concentration determinations by Emit.
    Matzke GR; Piveral K; Halstenson CE; Abraham PA
    Drug Intell Clin Pharm; 1984 Jun; 18(6):517-9. PubMed ID: 6376040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The excretion of 5-oxoproline in urine, as an index of glycine status, during normal pregnancy.
    Persaud C; McDermott J; De Benoist B; Jackson AA
    Br J Obstet Gynaecol; 1989 Apr; 96(4):440-4. PubMed ID: 2751957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Tobramycin concentration in human aqueous humor after intravenous administration].
    Hayashi M; Ito S; Miyashiro H
    Nippon Ganka Gakkai Zasshi; 1987 Nov; 91(11):1068-72. PubMed ID: 3445835
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pharmacokinetic characteristics during the period of pregnancy].
    Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 1987; 91(2):399-400. PubMed ID: 3685710
    [No Abstract]   [Full Text] [Related]  

  • 55. New sodium hydroxide digestion method for measurement of renal tobramycin concentrations.
    Gilbert DN; Kohlhepp SJ
    Antimicrob Agents Chemother; 1986 Sep; 30(3):361-5. PubMed ID: 3777902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of in-line filtration on tobramycin delivery.
    Elenbaas JK; Lander RD; Elenbaas RM
    Drug Intell Clin Pharm; 1985 Feb; 19(2):122-5. PubMed ID: 3882376
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The administration of tobramycin in the 2nd and 3rd trimester of pregnancy: contribution to a pharmacokinetic study for the adaptation of posology].
    Fernandez H; Bourget P; Delouis C; Demirdjian S
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(1):107-15. PubMed ID: 2019711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of tobramycin in pregnant women. Safety and efficacy of a once-daily dose regimen.
    Bourget P; Fernandez H; Delouis C; Taburet AM
    J Clin Pharm Ther; 1991 Jun; 16(3):167-76. PubMed ID: 1869596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Determination of the ratio of serum concentrations of tobramycin between fetus and mother at birth. A model of small scale pharmacokinetics].
    Bourget P; Fernandez H; Demirdjian S; Delouis C; Frydman R
    Arch Fr Pediatr; 1991 Oct; 48(8):543-7. PubMed ID: 1768193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selenium and malondialdehyde content and glutathione peroxidase activity in maternal and umbilical cord blood and amniotic fluid.
    Mihailović M; Cvetković M; Ljubić A; Kosanović M; Nedeljković S; Jovanović I; Pesut O
    Biol Trace Elem Res; 2000 Jan; 73(1):47-54. PubMed ID: 10949968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.